Correspondence 0001140361-25-008232 from Grace Therapeutics, Inc. (GRCE) (CIK 0001444192) (GRCE)
Grace Therapeutics, Inc. (GRCE) (CIK 0001444192)
Date: March 12, 2025 · CIK: 0001444192 · Accession: 0001140361-25-008232
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285661
Letter
Re: Grace Therapeutics, Inc.
GRACE THERAPEUTICS, INC. 103 Carnegie Center, Suite 300 Princeton, New Jersey 08540
March 12, 2025
VIA EDGAR
Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory
Registration Statement on Form S-3
Filed March 10, 2025
File No. 333-285661
Request for Acceleration of Effective Date
To Whom it May Concern,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Grace Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on March 13, 2025, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Steven Abrams of Hogan Lovells US LLP at (267) 675-4671. Also, please notify Mr. Abrams when this request for acceleration has been granted.
Very truly yours,
GRACE THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm GRACE THERAPEUTICS, INC. 103 Carnegie Center, Suite 300 Princeton, New Jersey 08540 March 12, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Grace Therapeutics, Inc. Registration Statement on Form S-3 Filed March 10, 2025 File No. 333-285661 Request for Acceleration of Effective Date To Whom it May Concern, Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Grace Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on March 13, 2025, or as soon thereafter as possible. Please direct any questions or comments concerning this request to Steven Abrams of Hogan Lovells US LLP at (267) 675-4671. Also, please notify Mr. Abrams when this request for acceleration has been granted. Very truly yours, GRACE THERAPEUTICS, INC. By: /s/ Prashant Kohli Name: Prashant Kohli Title: Chief Executive Officer